Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03153891 · ClinicalTrials.gov registry record · NA

Nature as a Buffer Among People With Chronic Pain

A NA study of Chronic Pain, sponsored by Cornell University.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT03153891 is a NA study of Chronic Pain that has completed, run by Cornell University. The registered enrollment target is 23 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03153891, a NA study of Chronic Pain, has completed, sponsored by Cornell University.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

This randomized controlled trial examines the effect of nature exposure on pain intensity levels among older adults who experience chronic pain. Investigators examine the effects of nature on: the experience of chronic pain, on pain catastrophizing, and on attention restoration.

Conditions Studied

Interventions

  • OTHER Built Environment
  • OTHER Natural Environment

Study Locations (1)

New York

  • Cornell University - Ithaca

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2016-07-01
Est. Completion 2018-06
Phase NA

Sponsor

Cornell University

66 total trials

What the Registry Record Tells You About NCT03153891

The ClinicalTrials.gov registry entry for NCT03153891 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (97% lower). The listed sponsor is Cornell University, which has 66 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Built Environment is the first listed.

NCT03153891 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03153891 about?

NCT03153891 is a clinical study titled "Nature as a Buffer Among People With Chronic Pain". This randomized controlled trial examines the effect of nature exposure on pain intensity levels among older adults who experience chronic pain. Investigators examine the effects of nature on: the experience of chronic pain, on pain catastrophizing, and on attention restoration.

What is the current status of trial NCT03153891?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2016-07-01. Estimated completion is 2018-06.

What conditions does trial NCT03153891 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT03153891?

The interventions under investigation include: Built Environment (OTHER), Natural Environment (OTHER).

Who is sponsoring clinical trial NCT03153891?

This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03153891 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.